Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Growth 2023-2029

Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Growth 2023-2029

Anti-Inflammatory Analgesic and Antipyretic Drug can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.

LPI (LP Information)' newest research report, the “Anti-Inflammatory Analgesic and Antipyretic Drugs Industry Forecast” looks at past sales and reviews total world Anti-Inflammatory Analgesic and Antipyretic Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-Inflammatory Analgesic and Antipyretic Drugs sales for 2023 through 2029. With Anti-Inflammatory Analgesic and Antipyretic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Inflammatory Analgesic and Antipyretic Drugs industry.

This Insight Report provides a comprehensive analysis of the global Anti-Inflammatory Analgesic and Antipyretic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Inflammatory Analgesic and Antipyretic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Anti-Inflammatory Analgesic and Antipyretic Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Inflammatory Analgesic and Antipyretic Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Inflammatory Analgesic and Antipyretic Drugs.

The global Anti-Inflammatory Analgesic and Antipyretic Drugs market size is projected to grow from US$ 2652 million in 2022 to US$ 2997.3 million in 2029; it is expected to grow at a CAGR of 2997.3 from 2023 to 2029.

Shandong Xinhua Pharmaceutical Company Limited and Mallinckrodt Pharmaceuticals are the top 2 manufacturers of antipyretic and analgesic raw materials globally and holds over 30% of global market share in total. Geographically speaking, North America holds about 25% of total market share, followed by China with over 20% share. In terms of type, paracetamol segment holds over half of total market share, followed by ibuprofen with over 20% share. In terms of end users, adult segment holds a dominant share of over 70%.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Inflammatory Analgesic and Antipyretic Drugs market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Paracetamol
Aspirin
Ibuprofen
Naproxen
Diclofenac
Oxaprozin
Dexibuprofen
Others

Segmentation by application
Adults
Children

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Mallinckrodt Pharmaceuticals
IOL
Anqiu Lu'an Pharmaceutical
Novacyl
BASF
Anhui BBCA Pharmaceuticals
Hubei Biocause
Xinhua Pharm
Granules India Limited
Huagang Pharm
Hebei Jiheng Pharmaceutical
Zhejiang Kangle Pharmaceutical
Hebei Jingye Medical Technology
MSPF
Lu'an Pharmaceutical
Mallinckrodt
Farmson
Anhui Fubore
SKPL
Atabay
Huzhou Konch Pharmaceutical
Anhui Topsun
SOLARA
SI Group

Key Questions Addressed in this Report

What is the 10-year outlook for the global Anti-Inflammatory Analgesic and Antipyretic Drugs market?

What factors are driving Anti-Inflammatory Analgesic and Antipyretic Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Anti-Inflammatory Analgesic and Antipyretic Drugs market opportunities vary by end market size?

How does Anti-Inflammatory Analgesic and Antipyretic Drugs break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.